IO Biotech (IOBT) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 5, 2025, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by June 4, 2025, 11:59 PM ET.

Voting matters and shareholder proposals

• Election of David Smith as director is up for shareholder vote, with board recommending approval.

• Ratification of EY Godkendt Revisionspartnerselskab as independent auditor for fiscal year ending December 31, 2025, is proposed, with board recommending approval.

Board of directors and corporate governance

• Board recommends the election of a single director nominee, David Smith, for the upcoming term.